Real-World Data Offering from Proscia: Empowering Life Sciences to Advance Precision Medicine Pipelines
recent articles
Roche (RHHBY) said that it has received CE Mark approval for the VENTANA HER2 (4B5) Rabbit Monoclonal Primary Antibody RxDx, enabling the identification of metastatic breast cancer patients with low HER2 expression who may benefit from ENHERTU...
PredxBio, Inc., a leader in spatially intelligent biology, and PictorLabs, Inc., a leading digital pathology firm pioneering AI-powered virtual staining technology, are pleased to announce a transformative partnership aimed at...
Lumea: Bringing together Acupath and AIRA Matrix, Lumea leverages its advanced tech to facilitate collaboration in digital pathology. LEHI, UTAH, UNITED STATES, March 25, 2024 /EINPresswire.com/ -- The combined collaboration of these three...
CHICAGO--(BUSINESS WIRE)--Nucleai, a spatial AI biomarker company that deciphers cellular conversations and maps cellular interactions within tissue samples to predict therapeutic outcomes, today announced a strategic collaboration...
Indica Labs and Molecular Instruments Announce Partnership to Advance AI-Powered Quantitative Image Analysis with HCR™ RNA-ISH Albuquerque, NM, and Los Angeles, CA 5 April 2024 — Indica Labs, a leading provider of AI-powered...
The Extension Funds Nucleai to Advance Its First-in-Class Spatial AI Biomarker in Active Clinical Enrollment Investment Expands Deployments of AI-Powered Spatial Biomarker Technology, Strengthening Companion Diagnostics for ADCs,...
